Brazil: untapped market for big pharma manufacturing
Pharmaceutical Technology
AUGUST 30, 2022
SUS provides full, free and universal access to healthcare for the country's entire population (215 million), which spends around 10% of its gross domestic product (GDP) on healthcare. Only a limited number of international pharma companies, however, operate manufacturing sites in the country.
195 
Let's personalize your content